Acadia Pharmaceuticals (ACAD) Current Taxes (2022 - 2024)

Acadia Pharmaceuticals' Current Taxes history runs 3 years deep, the most recent figure standing at $8.5 million for Q2 2024.

• In Q2 2024, Current Taxes changed N/A year-over-year to $8.5 million; the TTM figure through Jun 2024 stood at $8.5 million (changed N/A YoY), while the FY2023 annual figure was $8.7 million, up 2210.34% from the prior year.
• Current Taxes for Q2 2024 stood at $8.5 million, up from $7.6 million in the prior quarter.
• The five-year high for Current Taxes was $8.7 million in Q4 2023, with the low at $377000.0 in Q4 2022.
• The 3-year median for Current Taxes is $8.5 million (2023), against an average of $6.7 million.
• Peak annual rise in Current Taxes reached 2210.34% in 2023, while the deepest fall reached 2210.34% in 2023.
• Acadia Pharmaceuticals' Current Taxes stood at $377000.0 in 2022, then surged by 2210.34% to $8.7 million in 2023, then slipped by 2.92% to $8.5 million in 2024.
• Business Quant data shows ACAD's Current Taxes at $8.5 million in Q2 2024, $7.6 million in Q1 2024, and $8.7 million in Q4 2023.